Medical treatment with a dopamine agonist (most commonly bromocriptine or cabergoline) is the treatment of choice for most symptomatic prolactinomas, because these agents are highly effective at normalizing prolactin levels (∼60%–70%), restoring gonadal function (∼70%–90%) and decreasing tumor size (∼60%) [7]. Here, PRL is linked to neoplasm.